Guardant Health (GH) PT Lowered to $130 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Guardant Health (GH) PT Lowered to $110 at Cowen
February 24, 2022 6:42 AM ESTCowen analyst Max Masucci lowered the price target on Guardant Health (NASDAQ: GH) to $110.00 (from $170.00) while maintaining an Outperform rating.
The analyst commented, "With the ECLIPSE trial readout expected in mid-2022, GH is approaching another landmark event for the field of cancer... More
Guardant Health (GH) PT Lowered to $115 at Wells Fargo
February 24, 2022 6:36 AM ESTWells Fargo lowered its price target on Guardant Health (NASDAQ: GH) to $115.00 (from $150.00) while maintaining a Overweight rating.... More
Guardant Health (GH) PT Lowered to $120 at Citi
February 24, 2022 5:41 AM ESTCiti analyst Patrick Donnelly lowered the price target on Guardant Health (NASDAQ: GH) to $120.00 (from $180.00) while maintaining a Buy rating.... More
Guardant Health (GH) Tops Q4 EPS by 46c
February 23, 2022 4:15 PM ESTGuardant Health (NASDAQ: GH) reported Q4 EPS of ($0.69), $0.46 better than the analyst estimate of ($1.15). Revenue for the quarter came in at $108 million versus the consensus estimate of $98.61 million.
GUIDANCE:
Guardant Health sees FY2022 revenue of $460-470 million, versus the consensus of... More
